Tumour necrosis factor-alpha gene -238G/A promoter polymorphism associated with a more rapid onset of lipodystrophy.
Nolan
David
D
Centre for Clinical Immunology and Biomedical Statistics, and Department of Clinical Immunology and Biochemical Genetics, Royal Perth Hospital, Perth, Western Australia.
Moore
Corey
C
Castley
Alison
A
Sayer
David
D
Mamotte
Cyril
C
John
Mina
M
James
Ian
I
Mallal
Simon
S
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D015331:Cohort Studies; D018450:Disease Progression; D020022:Genetic Predisposition to Disease; D039682:HIV-Associated Lipodystrophy Syndrome / Q000235:genetics*; D006801:Humans; D011110:Polymorphism, Genetic; D011401:Promoter Regions, Genetic / Q000235:genetics; D016016:Proportional Hazards Models; D012307:Risk Factors; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics*
D014409:Tumor Necrosis Factor-alpha